Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Recruiting

Phase 2

Mirabegron & OxybutyninMirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Sponsor:

Kessler Foundation

Code:

NCT03187795

Conditions

Spinal Cord Injuries

Urinary Bladder, Neurogenic

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Oxybutynin Chloride IR

Mirabegron

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-15. This information was provided to ClinicalTrials.gov by Kessler Foundation on 2019-12-17.